ARCHIVES

Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill

This article is from The Cancer Letter archive.

Vol. 22 No. 37 | September 27, 1996

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982